806 related articles for article (PubMed ID: 11603885)
1. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL
J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
[TBL] [Abstract][Full Text] [Related]
2. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
Le Hellard S; Theisen FM; Haberhausen M; Raeder MB; Fernø J; Gebhardt S; Hinney A; Remschmidt H; Krieg JC; Mehler-Wex C; Nöthen MM; Hebebrand J; Steen VM
Mol Psychiatry; 2009 Mar; 14(3):308-17. PubMed ID: 18195716
[TBL] [Abstract][Full Text] [Related]
3. HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis.
De Luca V; Müller DJ; Hwang R; Lieberman JA; Volavka J; Meltzer HY; Kennedy JL
Hum Psychopharmacol; 2007 Oct; 22(7):463-7. PubMed ID: 17702092
[TBL] [Abstract][Full Text] [Related]
4. [Antipsychotic-induced weight gain--pharmacogenetic studies].
Olajossy-Hilkesberger L; Godlewska B; Marmurowska-Michałowskal H; Olajossy M; Landowski J
Psychiatr Pol; 2006; 40(5):1009-20. PubMed ID: 17217242
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.
Lett TA; Wallace TJ; Chowdhury NI; Tiwari AK; Kennedy JL; Müller DJ
Mol Psychiatry; 2012 Mar; 17(3):242-66. PubMed ID: 21894153
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
Arranz MJ; de Leon J
Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
[TBL] [Abstract][Full Text] [Related]
7. Genetic association between TNF-alpha -308 G>A polymorphism and longitudinal weight change during clozapine treatment.
Wang YC; Bai YM; Chen JY; Lin CC; Lai IC; Liou YJ
Hum Psychopharmacol; 2010; 25(4):303-9. PubMed ID: 20521320
[TBL] [Abstract][Full Text] [Related]
8. Risperidone-related weight gain: genetic and nongenetic predictors.
Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Lu CT; Chang WH
J Clin Psychopharmacol; 2006 Apr; 26(2):128-34. PubMed ID: 16633140
[TBL] [Abstract][Full Text] [Related]
9. The role of histaminergic H1 and H3 receptors in food intake: a mechanism for atypical antipsychotic-induced weight gain?
Deng C; Weston-Green K; Huang XF
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):1-4. PubMed ID: 19922755
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of antipsychotic-induced weight gain.
McIntyre RS; Mancini DA; Basile VS
J Clin Psychiatry; 2001; 62 Suppl 23():23-9. PubMed ID: 11603882
[TBL] [Abstract][Full Text] [Related]
11. Clozapine: weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation.
Wehmeier PM; Gebhardt S; Schmidtke J; Remschmidt H; Hebebrand J; Theisen FM
Psychiatry Res; 2005 Feb; 133(2-3):273-6. PubMed ID: 15741002
[TBL] [Abstract][Full Text] [Related]
12. DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain.
Popp J; Leucht S; Heres S; Steimer W
Pharmacogenomics J; 2009 Feb; 9(1):71-7. PubMed ID: 18332898
[TBL] [Abstract][Full Text] [Related]
13. Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.
Newcomer JW
J Clin Psychiatry; 2004; 65 Suppl 18():36-46. PubMed ID: 15600383
[TBL] [Abstract][Full Text] [Related]
14. Memantine-associated reversal of clozapine-induced weight gain.
Schaefer M; Leopold K; Hinzpeter A; Heinz A; Krebs M
Pharmacopsychiatry; 2007 Jul; 40(4):149-51. PubMed ID: 17694477
[TBL] [Abstract][Full Text] [Related]
15. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
[TBL] [Abstract][Full Text] [Related]
16. The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment.
Reynolds GP; Templeman LA; Zhang ZJ
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1021-8. PubMed ID: 15953671
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics of antipsychotics: useful for the clinician?
Bondy B; Spellmann I
Curr Opin Psychiatry; 2007 Mar; 20(2):126-30. PubMed ID: 17278909
[TBL] [Abstract][Full Text] [Related]
18. Genetic interactions in the adrenergic system genes: analysis of antipsychotic-induced weight gain.
De Luca V; Souza RP; Viggiano E; Sickert L; Teo C; Zai C; Tiwari AK; Müller DJ; Lieberman JA; Volavka J; Meltzer HY; Kennedy JL
Hum Psychopharmacol; 2011 Aug; 26(6):386-91. PubMed ID: 21823169
[TBL] [Abstract][Full Text] [Related]
19. Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
Stahl SM; Mignon L; Meyer JM
Acta Psychiatr Scand; 2009 Mar; 119(3):171-9. PubMed ID: 19178394
[TBL] [Abstract][Full Text] [Related]
20. A preliminary investigation of alpha-lipoic acid treatment of antipsychotic drug-induced weight gain in patients with schizophrenia.
Kim E; Park DW; Choi SH; Kim JJ; Cho HS
J Clin Psychopharmacol; 2008 Apr; 28(2):138-46. PubMed ID: 18344723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
